TEIRZA BRISTOW: Open Payments
NPI 1700363348 · KELLOGG, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 39 payments from 15 companies in 2025. Trend: 2023 $706 · 2024 $984 · 2025 $814
Food & beverage: $814
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $290 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $136 |
| PFIZER INC. | 3 | $57 |
| Amgen Inc. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Novo Nordisk Inc | 2 | $38 |
| Lilly USA, LLC | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
Products named: CAPLYTA, VRAYLAR, QULIPTA, UBRELVY, NURTEC ODT, TRELEGY ELLIPTA, Rybelsus, MOUNJARO.
Industry payments across ID — which companies pay providers there.
